Identification of human complement factor H as a chemotactic protein for monocytes

Area of Science:

• Immunology
• Biochemistry
• Oncology

Background:

• Mesothelioma is a rare cancer with limited treatment options.
• The tumor microenvironment in mesothelioma involves complex immune interactions.
• Understanding immune cell recruitment in mesothelioma is crucial for developing new therapies.

Purpose of the Study:

• To identify chemotactic proteins within mesothelioma pleural effusions.
• To elucidate the role of identified proteins in immune cell recruitment.
• To explore the potential therapeutic implications of these findings.

Main Methods:

• Chromatographic separation was used to purify proteins from mesothelioma pleural effusions.
• N-terminal amino acid sequencing and immunoblotting were employed for protein identification.
• Functional assays using specific antibodies were performed to assess chemotactic activity.

Main Results:

• A 150 kDa monomeric protein was purified and identified as complement factor H (CFH).
• Purified CFH exhibited significant monocyte chemotactic activity, with optimal activity at 10 nM.
• Antibodies against CFH inhibited the observed monocyte chemotactic activity.

Conclusions:

• Complement factor H possesses a novel function as a chemoattractant for monocytes in the context of mesothelioma.
• This chemotactic activity may contribute to malignant cell phagocytosis through the iC3b/complement receptor type 3 pathway.
• These findings highlight a link between the humoral and cellular immune systems in mesothelioma pathogenesis.